TESTBANKFORCLINICALIMMUNOLOGYANDSEROLOGYF7ALA
BORATORYPERSPECTIVE,5THEDITION,CHRISTINEF7DORREST
EYNSTEVENS,LINDAE.MILLERCOMPLETEF7CHAPTERS
LindaF7 E.F7 Miller,F7 ChristineF7 DorresteynF7 Stevens.F7 (2021),F7 ClinicalF7 immunologyF7 andF7 serolog
,ChapterF71.F7IntroductionF7toF7ImmunityF7andF7theF7ImmuneF7System
MultipleF7Choice
1.F7EosinophilsF7areF7involvedF7inF7theF7immuneF7responseF7against:F7vi
ruses.
intracellularF7bacteria.
parasitesF7thatF7cannotF7beF7phagocytized.F7ex
tracellularF7bacteria.
ANS:F7C
WhichF7ofF7theF7followingF7areF7componentsF7ofF7bothF7innateF7andF7adaptiveF7i
mmuneF7responses?F7A.F7Immunoglobulins
TF7helperF7cells
LindaF7 E.F7 Miller,F7 ChristineF7 DorresteynF7 Stevens.F7 (2021),F7 ClinicalF7 immunologyF7 an
d serolog
, MacrophagesF7
BF7cells
ANS:F7C
TheF7processF7byF7whichF7leukocytesF7areF7attractedF7toF7a specificF7areaF7byF7c
A
hemicalF7messengersF7isF7called:F7A.F7diapedesis.
degranulation.
F7chemotaxis.F7
opsonization.
ANS:F7C
WhichF7ofF7theF7followingF7isF7aF7characteristicF7ofF7naturalF7killerF7cells?F7
A.F7TheyF7matureF7inF7theF7thymus.
TheyF7areF7smallerF7thanF7BF7andF7TF7cells.F7
TheyF7areF7aF7typeF7ofF7lymphocyte.
TheyF7areF7partF7ofF7theF7adaptiveF7immuneF7system.
ANS:F7C
5.F7WhichF7ofF7theF7followingF7bestF7describesF7diapedesis?
LindaF7 E.F7 Miller,F7 ChristineF7 DorresteynF7 Stevens.F7 (2021),F7 ClinicalF7 immunologyF7 an
d serolog
, MovementF7towardF7increasingF7concentrationsF7ofF7aF7cytokineF
7AttachmentF7ofF7immunoglobulinF7toF7targetF7cells
MovementF7throughF7bloodF7vesselF7wallsF7asF7cellsF7exitF7theF7circulation
EngulfmentF7ofF7targetF7cellsF7A
NS:F7C
TheF7mostF7effectiveF7phagocyticF7andF7antige
n-F7presentingF7cellF7isF7the:F7A.F7neutrophil.
monocyte.F7d
endriticF7cell.F
7 macrophage.
ANS:F7C
WhichF7ofF7theF7followingF7isF7characteristicF7ofF7naturalF7immunity?F7A.F7ItF7in
volvesF7memory.
TF7lymphocytesF7playF7aF7majorF7rol
e.F7ItF7involvesF7specificity.
MechanismsF7areF7alwaysF7presentF7andF7fullyF7functional
.F7ANS:F7D
LindaF7 E.F7 Miller,F7 ChristineF7 DorresteynF7 Stevens.F7 (2021),F7 ClinicalF7 immunologyF7 an
d serolog
BORATORYPERSPECTIVE,5THEDITION,CHRISTINEF7DORREST
EYNSTEVENS,LINDAE.MILLERCOMPLETEF7CHAPTERS
LindaF7 E.F7 Miller,F7 ChristineF7 DorresteynF7 Stevens.F7 (2021),F7 ClinicalF7 immunologyF7 andF7 serolog
,ChapterF71.F7IntroductionF7toF7ImmunityF7andF7theF7ImmuneF7System
MultipleF7Choice
1.F7EosinophilsF7areF7involvedF7inF7theF7immuneF7responseF7against:F7vi
ruses.
intracellularF7bacteria.
parasitesF7thatF7cannotF7beF7phagocytized.F7ex
tracellularF7bacteria.
ANS:F7C
WhichF7ofF7theF7followingF7areF7componentsF7ofF7bothF7innateF7andF7adaptiveF7i
mmuneF7responses?F7A.F7Immunoglobulins
TF7helperF7cells
LindaF7 E.F7 Miller,F7 ChristineF7 DorresteynF7 Stevens.F7 (2021),F7 ClinicalF7 immunologyF7 an
d serolog
, MacrophagesF7
BF7cells
ANS:F7C
TheF7processF7byF7whichF7leukocytesF7areF7attractedF7toF7a specificF7areaF7byF7c
A
hemicalF7messengersF7isF7called:F7A.F7diapedesis.
degranulation.
F7chemotaxis.F7
opsonization.
ANS:F7C
WhichF7ofF7theF7followingF7isF7aF7characteristicF7ofF7naturalF7killerF7cells?F7
A.F7TheyF7matureF7inF7theF7thymus.
TheyF7areF7smallerF7thanF7BF7andF7TF7cells.F7
TheyF7areF7aF7typeF7ofF7lymphocyte.
TheyF7areF7partF7ofF7theF7adaptiveF7immuneF7system.
ANS:F7C
5.F7WhichF7ofF7theF7followingF7bestF7describesF7diapedesis?
LindaF7 E.F7 Miller,F7 ChristineF7 DorresteynF7 Stevens.F7 (2021),F7 ClinicalF7 immunologyF7 an
d serolog
, MovementF7towardF7increasingF7concentrationsF7ofF7aF7cytokineF
7AttachmentF7ofF7immunoglobulinF7toF7targetF7cells
MovementF7throughF7bloodF7vesselF7wallsF7asF7cellsF7exitF7theF7circulation
EngulfmentF7ofF7targetF7cellsF7A
NS:F7C
TheF7mostF7effectiveF7phagocyticF7andF7antige
n-F7presentingF7cellF7isF7the:F7A.F7neutrophil.
monocyte.F7d
endriticF7cell.F
7 macrophage.
ANS:F7C
WhichF7ofF7theF7followingF7isF7characteristicF7ofF7naturalF7immunity?F7A.F7ItF7in
volvesF7memory.
TF7lymphocytesF7playF7aF7majorF7rol
e.F7ItF7involvesF7specificity.
MechanismsF7areF7alwaysF7presentF7andF7fullyF7functional
.F7ANS:F7D
LindaF7 E.F7 Miller,F7 ChristineF7 DorresteynF7 Stevens.F7 (2021),F7 ClinicalF7 immunologyF7 an
d serolog
